Research & News

New Dosing Recommendations for HIV-Infected Infants

Nov 05, 2009

The Food and Drug Administration (FDA) approved revised pediatric dosing recommendations for zidovudine that expand dosing to include children starting treatment at four weeks of age. To read the FDA notification, click here.

Full Results of AIDS Vaccine Trial Now Available

Oct 22, 2009

The full results of a landmark AIDS vaccine trial conducted in Thailand confirm that the vaccine offered limited success in protecting recipients from HIV. For more information, click here.

NIH Starting H1N1 Vaccine Trial in Pregnant Women with HIV

Oct 15, 2009

The National Institutes of Health (NIH) are funding a clinical trial of the H1N1 vaccine in pregnant women with HIV to determine its effectiveness in women with weakend immune systems from the HIV virus. The trial will involve a higher than normal dose of the vaccine to... Read More

HIV Vaccine Study Shows Promising Results

Sep 28, 2009

A new HIV vaccine regimen that was tested among more than 16,000 young adults in Thailand showed some preventive effect against HIV infection. Click to view the press release.

Obstetric and Newborn Outcomes in HIV-Infected Women Receiving HAART

Sep 17, 2009

A recent study examined perinatal outcomes in HIV-infected women receiving highly active antiretroviral therapy (HAART) compared with the general population. HIV-positive women were found to be at higher risk for preterm birth and lower birthweight infants. Additionally,... Read More

Maternal ART Reduces Transmission of HIV Through Breast Feeding

Sep 01, 2009

A study recently presented at the 2009 International AIDS Society conference found that in a breast feeding population of women in Botswana, the rate of mother-to-child transmission was 1% among women who received ART through six months postpartum. The study authors... Read More

Hotline Participates in CDC National HIV Prevention Conference

Sep 01, 2009

Hotline staff recently presented two posters at the CDC's 2009 National HIV Prevention Conference in Atlanta, Georgia. The posters demonstrated improvements in perinatal HIV testing in Illinois and ethnoracial and prenatal care differences in women presenting with positive... Read More

In Utero Infections Linked with Increased Risk of Nevirapine Resistance

Aug 30, 2009

A recent study of Ugandan infants revealed that in utero HIV infection was the only factor associated with nevirapine resistance detected in infants 6-8 weeks after sdNVP exposure. Citation:Church JD, Mwatha A, Bagenda D, Omer SB, Donnell D, Musoke P, Nakabiito C, Eure C,... Read More

Resistance to Antiretrovirals in HIV-Infected Pregnant Women

Aug 30, 2009

In a study to determine the prevalence of resistance to ARV prior to treatment and its effect on the pregnancy outcome, investigators found that resistance to antiretrovirals was common in antiretroviral-experienced patients, but not in naive women. The study's findings of... Read More

Rapid HIV Testing is Feasible and Provides Faster Results Than Conventional Testing

Aug 27, 2009

The Mother-Infant Rapid Intervention at Delivery (MIRIAD) study demonstrated that women overwhelmingly accepted testing, and rapid HIV testing provided faster results than conventional testing with point-of-care rapid testing providing the fastest results. Citation:Tepper... Read More

Pages